Updated information and services can be found at: Only ␥-chain T-cell receptor transcripts utilizing V-I subgroup gene segments were found in peripheral blood lymphocytes from a patient with Omenn's syndrome. ␥-Chain T-cell receptor transcripts utilizing the V ␥ 9 (V-II subgroup) gene segment were absent in peripheral blood lymphocytes from this patient. V ␥ 9 J ␥ 1.2 C ␥ 1 rearrangements are those primarily found in peripheral blood lymphocytes (70 to 85%) from normal donors.
Omenn's syndrome is an autosomal recessive combined immunodeficiency with hypereosinophilia (19) , presenting early in life with widespread erythroderma, protracted diarrhea, hepatosplenomegaly, lymphadenopathy, and failure to thrive (19) . There is severe lymphocyte depletion in the thymus and lymph nodes, in contrast to a high number of poorly functional T cells in the peripheral blood as well as infiltrating the skin, gut, liver, and spleen (7, 19, 23) . It has been suggested that the basis of this syndrome is graft versus host disease caused by engraftment of maternal lymphocytes; however, no evidence supporting this hypothesis has been found (7, 23, 28) . The syndrome appears to represent an intrinsic lymphocytic lineage defect, and it is curable by bone marrow transplantation (9) .
The ␥␦ T-cell receptor (TCR) utilizes two different constant region gene segments, the C ␥ 1 and the C ␥ 2 (2, 5, 10, 11) . ␥␦ TCRs employing the C ␥ 1 gene segment are disulfide-linked, whereas those employing the C ␥ 2 segment are non-disulfidelinked (2, 5, 10, 11) . Due to their genomic organization, J ␥ 1 (1.1, 1.2, and 1.3) gene segments exclusively rearrange to the C ␥ 1 gene segment and J ␥ 2 (2.1, 2.3) gene segments exclusively rearrange to the C ␥ 2 gene segment (reviewed in reference 1). We have shown (13) that in the peripheral blood of normal individuals, V-I subgroup human ␥-chain TCR gene segments preferentially rearranged with J ␥ 2.1 C ␥ 2 or J ␥ 2.3 C ␥ 2 gene segments. In contrast, Ͼ85% of the ␥-chain transcripts in the peripheral blood that utilize the V-II subgroup (V ␥ 9) gene segment exclusively rearranged to J ␥ 1.2 C ␥ 1 gene segments (26) .
We report here that peripheral blood lymphocytes from a patient with Omenn's syndrome exhibited a restricted pattern of rearrangements of the ␥-chain TCR genes. We amplified by PCR ␥-chain cDNAs from the peripheral blood lymphocytes from this patient and cloned and sequenced the amplified cDNAs. Exclusive utilization of V-I subgroup gene segments was observed, and these were rearranged to J ␥ 2.3 C ␥ 2 gene segments. cDNAs utilizing the V ␥ 9 J ␥ 1 (1.1, 1.2, and 1.3) C ␥ 1 gene segments were not observed in the peripheral blood lymphocytes of this patient. V ␥ 9 J ␥ 1.2 C ␥ 1 rearrangements are those used primarily (70 to 85%) by peripheral blood lymphocytes in normal donors (26) .
(These findings were presented in part at the 1991 Annual Meeting of the Federation of American Societies for Experimental Biology, Atlanta, Ga. [9a] .)
Heparinized peripheral blood was obtained from a 2-monthold Caucasian female infant, who was admitted to the All Children's Hospital and diagnosed with Omenn's syndrome. The patient exhibited generalized desquamative rash since birth and generalized lymphadenopathy and massive splenomegaly of unknown etiology. A skin biopsy showed spongiotic dermatitis with scattered necrotic keratinocytes, a finding consistent with the diagnosis of Omenn's syndrome.
Significant T-cell lymphocytosis was evident in the peripheral blood. Over the second month of the life of the patient, leukocytes were consistently significantly elevated (50,000 to 79,800 cells per mm 3 ; range, 4 determinations), and lymphocytes accounted for 56 to 80% of leukocytes. Moderately high levels of eosinophils were consistently observed. Representative results of a differential count were as follows: leukocytes, 50,000 per mm 3 ; 4% segmented; 1% band; 79% lymphocytes; 1% monocytes; and 9% eosinophils. Flow cytometry analysis of mononuclear cells was carried out by standard methods using a battery of monoclonal antibodies. The following results were obtained (Leukocyte and lymphocyte counts were 79,800 cells per mm 3 and 63,814 cells per mm 3 , respectively): CD2, 99%; CD3, 93% (59,371 cells per mm 3 ); CD4, 37%; CD8, 56%; CD4/CD8, 0.7; CD5, 93%; CD7, 81%; and CD16, 7%. The proportion of B cells was reduced (to 1%) (kappa, 2%; lambda, 0%); however, their absolute numbers were normal for the age of the patient (638 cells per mm 3 ). Similar results were obtained in an additional determination at a different time. A lymph node biopsy demonstrated abnormal lymph node architecture. The lymph nodes exhibited a granulomatous appearance, and large numbers of lymphocytes were present and were predominantly CD8 cells. Specifically, flow cytometry analysis of lymph node lymphocytes revealed the presence of the following populations: CD3, 76%; CD2, 76%; CD4, 12%; CD8, 52%; CD20, 12%; CD19, 0%; CD10, 0%; and CD33, 20%. Kappa and lambda chain-positive cells were not detected. Increased proportions of cells of the monocyte-macrophage lineage (25%) were also present. The combined proportions of CD4 ϩ and CD8 ϩ cells (64%) were lower than that of CD3 ϩ cells (76%), in agreement with reports in the literature (8, 28, 29) Mononuclear cells were isolated by centrifugation on a Ficoll-Hypaque density cushion, as previously described (20) , from heparinized peripheral blood from normal donors or the patient with Omenn's syndrome. The mononuclear cells were passed through a nylon wool column (12) , and the nonadherent cells were isolated and treated with OKT4 (anti-CD4) and anti-Leu11 (anti-CD16) monoclonal antibodies plus rabbit complement, as previously described (20) . CD4
Ϫ and CD16 Ϫ cells were used for isolation of total RNA, as described previously (13) . ␥-Chain TCR-specific first-strand cDNA was synthesized by using a C ␥ -specific primer (5ЈTGTGAGCTGCAG CAGTAGAGTAT3Ј), and the cDNA was amplified by PCR in a Thermocycler (Perkin-Elmer Cetus), as previously described (13) . The following amplification steps were carried out: denaturation for 1 min at 95ЊC, annealing for 2 min at 55ЊC, and extension for 3 min at 72ЊC. A set of primers specific for the variable and constant gene segments were used as previously described (13) . The V region (5Ј-end) primers were specific for the V-I subgroup (5ЈTGCGGTGGGCCCTACTGGTGCTT 3Ј) (V ␥ 2, V ␥ 3, V ␥ 4, and V ␥ 5) or the V-II subgroup (5ЈTGCT GTCACTGCTCCACACATC3Ј) (V ␥ 9). The following C ␥ primer was used as the 3Ј-end amplification primer: 5ЈGCCT TCTGGAGCTTTGTTTCAG3Ј. The amplified cDNAs were purified by Centricon-100 centrifugation (Amicon, Danvers, Mass.) and cloned into the pUC18 vector, and the recombinant plasmids were used to transform DH5␣ Escherichia coli cells, as previously described (13) . White bacterial colonies were screened by filter hybridization by using a 5Ј-end 32 P-labelled C ␥ -specific screening probe (5ЈGGAAGAAAAATAGTGGG CTTGG3Ј), as previously described (13) . This probe is specific for both C ␥ 1 and C ␥ 2 gene segments, and it is located 5Ј to the C ␥ amplification primer. Thirteen clones were sequenced (Fig.  1) by the Sanger dideoxy method, as previously described (13) . None of these clones were found in the GenBank database. All 3) C ␥ 1 gene segments were not observed in the peripheral blood lymphocytes of this patient. This pattern of rearrangements is in contrast to rearrangements in peripheral blood lymphocytes of normal individuals, which preferentially use V ␥ 9 (V-II subgroup) rearrangements to J ␥ 1 C ␥ 1 gene segments (26) . We examined the expression of the V ␥ 9 (V-II) gene segment in peripheral blood cDNAs amplified by PCR in three normal individuals (13) . Under identical experimental conditions, including PCR primer concentrations, we identified a significant number of V ␥ 9 clones (13). All the sequenced V ␥ 9 clones exhibited rearrangements to J ␥ 1 C ␥ 1 gene segments. Conclusions regarding the exact level of expression of the different V ␥ segments (V ␥ 1 versus V ␥ 9) cannot be drawn, since our experiments are not quantitative. However, the absolute lack of V ␥ 9 clones under identical experimental conditions of amplification and cloning is significant. de Saint-Basille et al. (8) demonstrated that all ␥␦ TCR ϩ T lymphocytes in a patient with Omenn's syndrome were labelled by an anti-V ␦ 1-J ␦ 1 monoclonal antibody (␦TCS1) (29) , while anti-V ␥ 9 and anti-V ␦ 2 did not label the ␥␦ TCR ϩ T cells. Although the anti-␦TCS1 monoclonal antibody reacts with both disulfide-linked and non-disulfide-linked ␥␦ TCR ϩ T-cell clones (18, 21, 24) , the vast majority of peripheral blood ␦TCS1 ϩ T lymphocytes express non-disulfide-linked ␥␦ TCR (4). These reported findings (8) are in agreement with ours. This particular patient (8) expressed increased proportions (determined by two-color flow cytometry) of ␥␦ TCR ϩ T cells. In addition, de Saint-Basille et al. (8) investigated the TCR genomic DNA rearrangements of peripheral blood or tissue lymphocytes by Southern blotting, using appropriate C ␤ , J ␦ , and J ␥ probes. Different non-germline ␤-, ␥-and ␦-chain TCR gene rearrangements were observed in these patients. The degree of oligoclonality of these non-germline rearrangements varied among different patients, and their functional significance is unknown.
A common feature of the preferentially expanded ␥␦ TCR ϩ or ␣␤ TCR ϩ T cells in Omenn's syndrome appears to be that they comprise DN T cells (CD3 ϩ CD4 Ϫ CD8 Ϫ ) (8, 28, 29) . Preferential expansion of oligoclonal V␤14 ϩ DN T cells may account for the abnormal expression of certain cytokines (14) . Interleukin-4 (IL-4) upregulates, while IL-2 and gamma interferon downregulate, immunoglobulin E production (15, 22) . IL-5 enhances eosinophil maturation and degranulation (6). Melamed et al. (14) described the expansion of a DN T-cell population preferentially utilizing the V ␤ 14 gene segment in a patient with Omenn's syndrome. These T cells expressed increased levels of IL-5 and decreased levels of IL-2 and gamma interferon, suggesting an association between these expanded DN T cells and the observed cytokine pattern.
Our results as well as those of de Saint-Basille et al. (8) suggest that peripheral blood T lymphocytes from patients with Omenn's syndrome do not utilize the V ␥ 9 gene segment. In addition, we have previously shown (5, 11, 17, 18, 21, 24, 25) that the majority of ␥␦ TCR ϩ T-cell lines derived from the peripheral blood of patients with primary immunodeficiency disorders expressed primarily non-disulfide-linked ␥␦ TCR. In contrast, most T-cell lines and 80 to 95% of T-cell clones derived from the peripheral blood of normal donors expressed mostly disulfide-linked ␥␦ TCR utilizing the C ␥ 1 gene segment (16) (17) (18) . These results suggested a difference in the type of the ␥␦ TCR expressed by T cells derived from the peripheral blood of patients with primary immunodeficiency disorders and those derived from the peripheral blood of normal donors. This relatively increased expression of a non-disulfide-linked form of ␥␦ TCR found in a number of other primary immunodeficiencies as well, especially severe combined immunodeficiency, is of great interest. It remains to be determined whether T cells expressing non-disulfide-linked ␥␦ TCR have different properties than those expressing disulfide-linked ␥␦ TCR and whether the former appear first in development.
The restricted TCR heterogeneity in Omenn's syndrome is a common feature of both ␥␦ and ␣␤ TCR (28) . This observation suggests that although a restricted TCR heterogeneity is present, no predilection for expression of ␣␤ versus ␥␦ TCR has been noted, suggesting a spectrum of abnormalities of lymphocytic lineage rather than a single defect. On the other hand, it has been suggested that this restricted heterogeneity of TCR expression actually represents a "leaky" variant of SCID, as has been described in SCID mice (3) . This leakiness could result from extrathymic T-cell differentiation or escape of negative selection in the thymus (27) and subsequent specific antigen-driven selective expansion of "auto-immune" T-cell clones. Evidence can be cited both in favor and against either of these hypotheses, and it remains to be shown which is the prevailing mechanism.
Identification of the molecular and cellular defects in Omenn's syndrome is critical for our understanding of the pathogenesis of the disease and of the molecular basis of the immunodeficiency as well as the steps of T-cell differentiation in vivo.
